Testing XEN1101 against a placebo for primary generalized tonic-clonic seizures
Explore this study →
Sites in Lethbridge, London and 2 more cities
RecruitingPHASE3
Official title: A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Primary Generalized Tonic-Clonic Seizures · Xenon Pharmaceuticals Inc.